PHARVARIS N V's ticker is PHVS and the CUSIP is N69605108. A total of 34 filers reported holding PHARVARIS N V in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $691,674 | +33.8% | 33,142 | -2.9% | 1.10% | +192.1% |
| Q2 2023 | $516,910 | +88.0% | 34,142 | 0.0% | 0.38% | +86.2% |
| Q1 2023 | $275,014 | -28.4% | 34,142 | 0.0% | 0.20% | -31.9% |
| Q4 2022 | $384,098 | +46.6% | 34,142 | 0.0% | 0.30% | +48.3% |
| Q3 2022 | $262,000 | -65.3% | 34,142 | 0.0% | 0.20% | -61.9% |
| Q2 2022 | $755,000 | +22.0% | 34,142 | 0.0% | 0.53% | +108.3% |
| Q1 2022 | $619,000 | +26.1% | 34,142 | 0.0% | 0.25% | +109.1% |
| Q4 2021 | $491,000 | -92.4% | 34,142 | -90.6% | 0.12% | -94.0% |
| Q3 2021 | $6,456,000 | -4.8% | 364,142 | 0.0% | 2.01% | -24.8% |
| Q2 2021 | $6,784,000 | -63.5% | 364,142 | -45.2% | 2.67% | -51.1% |
| Q1 2021 | $18,583,000 | – | 664,142 | – | 5.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 3,261,926 | $57,834,000 | 8.52% |
| venBio Partners LLC | 2,303,310 | $40,838,000 | 4.07% |
| Bain Capital Life Sciences Investors, LLC | 3,180,601 | $56,392,000 | 3.50% |
| Foresite Capital Management V, LLC | 364,142 | $6,456,000 | 2.01% |
| VR Adviser, LLC | 552,882 | $9,803,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,608,471 | $28,518,000 | 0.56% |
| Cormorant Asset Management, LP | 689,731 | $12,229,000 | 0.50% |
| Novo Holdings A/S | 418,943 | $7,428,000 | 0.38% |
| GENERAL ATLANTIC, L.P. | 2,420,155 | $42,909,000 | 0.25% |
| DAFNA Capital Management LLC | 35,074 | $622,000 | 0.16% |